US$ 28.40
gastric pentadecapeptide bpc 157 | bpc-157 derived from gastric juice
Description
A short non-diabetic cohort measured a flat 2.5 mg dose for about four weeks and found weight and insulin-resistance movement (about -4.7% body weight). That makes "2.5 mg has no data" outdated
PLEASE share your progress and any tips on what worked is working for you

Opioid tolerance and dependence: An inevitable consequence of chronic treatment

What Are Trigger Points

The result is amplified proliferative signals without increasing hormone levels

This is not about crash diets or suppressing appetite
